Emerging genetic complexity and rare genetic variants in neurodegenerative brain diseases

Abstract

Knowledge of the molecular etiology of neurodegenerative brain diseases (NBD) has substantially increased over the past three decades. Early genetic studies of NBD families identified rare and highly penetrant deleterious mutations in causal genes that segregate with disease. Large genome-wide association studies uncovered common genetic variants that influenced disease risk. Major developments in next-generation sequencing (NGS) technologies accelerated gene discoveries at an unprecedented rate and revealed novel pathways underlying NBD pathogenesis. NGS technology exposed large numbers of rare genetic variants of uncertain significance (VUS) in coding regions, highlighting the genetic complexity of NBD. Since experimental studies of these coding rare VUS are largely lacking, the potential contributions of VUS to NBD etiology remain unknown. In this review, we summarize novel findings in NBD genetic etiology driven by NGS and the impact of rare VUS on NBD etiology. We consider different mechanisms by which rare VUS can act and influence NBD pathophysiology and discuss why a better understanding of rare VUS is instrumental for deriving novel insights into the molecular complexity and heterogeneity of NBD. New knowledge might open avenues for effective personalized therapies.

Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform

“…It was suggested that KCNB2 was one of the genes with the most significant copy number gains in ALS ( Morello et al, 2018 ). KCNS3 was reported to be upregulated in early pathological stages of AD ( Saura et al, 2015 ), and as a risk gene in PD ( Perrone et al, 2021 ). Administration of 4-Aminopyridine, a non-selective blocker of Kv channels, restored ion channel dynamics, rescued neuronal activity, and relieved ER stress in ALS MNs ( Naujock et al, 2016 ), reinforcing our hypothesis.…”

Modelling and Refining Neuronal Circuits with Guidance Cues: Involvement of Semaphorins

“…Neurodegeneration is a progressive and non-reversable process affecting the physiology of CNS and/or PNS plasticity [ 94 , 95 ]. These diseases are mainly linked to genetic mutations, which eventually manifest as pathological when affecting new protein synthesis and homeostasis [ 95 , 96 ].…”

TRIM family proteins: roles in proteostasis and neurodegenerative diseases

“…Proteostasis disruption has serious consequences such as the pathogenesis of a variety of disorders, including NDs, ageing and cancer [18][19][20]. Additionally, mutations in genes encoding pathogenic proteins can cause misfolding and sequential aggregation in NDs [21]. The proteostasis network can clear aggregated proteins in the absence of gene mutations; however, this capacity declines with age, resulting in proteostasis dysfunction [22].…”